Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease
- PMID: 16391616
- DOI: 10.1038/ncpcardio0380
Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease
Abstract
Abdominal fat accumulation has been shown to play crucial roles in the development of metabolic syndrome. Visceral fat accumulation particularly is closely correlated to the development of cardiovascular disease and obesity-related disorders such as diabetes mellitus, hyperlipidemia and hypertension. Given these clinical findings, the functions of adipocytes have been intensively investigated in the past 10 years, and have been revealed to act as endocrine cells that secrete various bioactive substances termed adipocytokines. Among adipocytokines, tumor-necrosis factor-alpha, plasminogen activator inhibitor type 1 and heparin-binding epidermal growth factor-like growth factor are produced in adipocytes as well as other organs, and contribute to the development of vascular diseases. Visfatin has been identified as a visceral-fat-specific protein that might be involved in the development of obesity-related diseases, such as diabetes mellitus and cardiovascular disease. In contrast to these adipocytokines, adiponectin, which is an adipose-tissue-specific, collagen-like protein, has been noted as an important antiatherogenic and antidiabetic protein, or as an anti-inflammatory protein. The functions of adipocytokine secretion might be regulated dynamically by nutritional state. Visceral fat accumulation causes dysregulation of adipocyte functions, including oversecretion of tumor-necrosis factor-alpha, plasminogen activator inhibitor type 1 and heparin-binding epidermal growth factor-like growth factor, and hyposecretion of adiponectin, which results in the development of a variety of metabolic and circulatory diseases. In this review, the importance of adipocytokines, particularly adiponectin, is discussed with respect to cardiovascular diseases.
Similar articles
-
The metabolic syndrome and adipocytokines.FEBS Lett. 2006 May 22;580(12):2917-21. doi: 10.1016/j.febslet.2006.04.028. Epub 2006 Apr 21. FEBS Lett. 2006. PMID: 16674947 Review.
-
The metabolic syndrome and adipocytokines.Expert Rev Clin Immunol. 2007 Jan;3(1):39-46. doi: 10.1586/1744666X.3.1.39. Expert Rev Clin Immunol. 2007. PMID: 20476950
-
Adipocytokines and metabolic syndrome.Semin Vasc Med. 2005 Feb;5(1):34-9. doi: 10.1055/s-2005-871744. Semin Vasc Med. 2005. PMID: 15968578 Review.
-
White adipose tissue and cardiovascular disease.Best Pract Res Clin Endocrinol Metab. 2005 Dec;19(4):637-47. doi: 10.1016/j.beem.2005.07.001. Best Pract Res Clin Endocrinol Metab. 2005. PMID: 16311222 Review.
-
Adiponectin: linking the metabolic syndrome to its cardiovascular consequences.Expert Rev Cardiovasc Ther. 2005 May;3(3):465-71. doi: 10.1586/14779072.3.3.465. Expert Rev Cardiovasc Ther. 2005. PMID: 15889974 Review.
Cited by
-
Computed tomographic abdominal fat volume estimation - a handy tool to predict the risk of metabolic syndrome.Pol J Radiol. 2023 Aug 21;88:e379-e388. doi: 10.5114/pjr.2023.131010. eCollection 2023. Pol J Radiol. 2023. PMID: 37701173 Free PMC article.
-
Characterization of Green and Yellow Papaya (Carica papaya) for Anti-Diabetic Activity in Liver and Myoblast Cells and Wound-Healing Activity in Fibroblast Cells.Nutrients. 2023 Apr 17;15(8):1929. doi: 10.3390/nu15081929. Nutrients. 2023. PMID: 37111148 Free PMC article.
-
Adiponectin can be a good predictor of urodynamic detrusor underactivity: a prospective study in men with lower urinary tract symptoms.World J Urol. 2023 Apr;41(4):1117-1124. doi: 10.1007/s00345-023-04341-y. Epub 2023 Feb 24. World J Urol. 2023. PMID: 36823359
-
Brazilian Propolis Intake Decreases Body Fat Mass and Oxidative Stress in Community-Dwelling Elderly Females: A Randomized Placebo-Controlled Trial.Nutrients. 2023 Jan 11;15(2):364. doi: 10.3390/nu15020364. Nutrients. 2023. PMID: 36678234 Free PMC article. Clinical Trial.
-
High polygenic risk score for exceptional longevity is associated with a healthy metabolic profile.Geroscience. 2023 Feb;45(1):399-413. doi: 10.1007/s11357-022-00643-y. Epub 2022 Aug 16. Geroscience. 2023. PMID: 35972662 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous